@article {Kjellstrand65, author = {Carl M. Kjellstrand and Carl Kovithavongs and Erika Szabo}, title = {International Comparison of the Success, Cost, and Efficiency of Modern Medicine}, volume = {3}, number = {3}, pages = {65--77}, year = {2000}, doi = {10.3905/jpe.2000.319970}, publisher = {Institutional Investor Journals Umbrella}, abstract = {Traditional {\textquotedblleft}western{\textquotedblright} medicine has been highly successful in the ten industrialized countries studied for the period from 1980 to 1990. By studying mortality in six diseases deemed amenable to treatment ({\textquotedblleft}avoidable{\textquotedblright} deaths), as well as mortality for {\textquotedblleft}unavoidable{\textquotedblright} diseases (primarily degenerative and genetic conditions), and correlating them to health care expenditures, the authors were able to analyze the efficiency of countries{\textquoteright} efforts to reduce mortality rates. The lag between spending and health outcomes, as well as the extent of the correlation between expenditures as a percentage of a country{\textquoteright}s GDP and its mortality rates, may inform and illuminate both fiscal and medical decisions for the future.}, issn = {1096-5572}, URL = {https://jpe.pm-research.com/content/3/3/65}, eprint = {https://jpe.pm-research.com/content/3/3/65.full.pdf}, journal = {The Journal of Private Equity (Retired)} }